Differential enhancement of postischemic segmental systolic thickening by diltiazem  by Taylor, Anne L. et al.
JACC Vol. 15, No. 3 
March I, 1990:737-47 
137 
Differential Enhancement 
Thickening by Diltiazem 
of Postischemic Segmental Systolic 
ANNE L. TAYLOR, MD, FACC, PAOLO GOLINO, MD, ROBIN ECKELS, AA, 
PATRICIA PASTOR, MA, L. MAXIMILIAN BUJA, MD, FACC, 
JAMES T. WILLERSON, MD, FACC 
Dallas, Texas 
Prolonged depression of segmental systolic thickening after 
brief coronary artery occlusion may result principally from 
events during reperfusion rather than during the ischemic 
interval. Thus, cellular calcium overload at reperfusion 
may be a mediator of contractile dysfunction after brief 
Thirteen awake unsedated dogs instrumented with he- 
modynamic catheters, left anterior descending coronary 
ischemia, and reduction of calcium entry by diltiazem, a 
artery occluders and five to six pairs of intramyocardial 
sonomicrometers underwent two 15 min coronary artery 
calcium channel antagonist, may enhance recovery of sys- 
occlusions with 24 h reperfusion. The order of infusion of 
diltiazem (15 &kg per mitt) or saline solution was alter- 
tolic thickening after brief periods of ischemia. 
nated. Systolic thickening, hemodynamic variables and 
regional myocardial blood flow were measured serially over 
24 h. Despite equally severe ischemic dysfunction during 
coronary occlusion, diltiazem-treated segments with sys- 
tolic thinning during ischemia recovered control segmental 
thickening significantly earlier than saline solution-treated 
segments (at 30 versus 180 min of reperfusion). Blood 
pressure was mildly decreased during diltiazem treatment; 
The evolution of regional systolic function after transient 
myocardial ischemia is a complex function of cellular events 
occurring during the ischemic period, as well as events 
occurring at reperfusion. Despite the fact that timely reper- 
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therefore, a second group of 10 dogs underwent a similar 
occlusion and reflow period during infusion of nitroprus- 
side to lower mean arterial pressure equivalently. De- 
creases in blood pressure in this group resulted in some 
Thus, it is concluded that 1) diltiazem infusion signifi- 
cantly enhanced recovery of segmental systolic thickening 
improvement in segmental systolic function; however, this 
after 15 min of ischemia and 24 h of reperfusion; 2) the 
did not reach statistical significance at any time. Regional 
enhancement in segmental systolic function could not en- 
tirely be attributed to decreased mean arterial pressure; 
myocardial blood flows were similar in the saline solution- 
3) improvement in postischemic segmental ventricular 
function was seen only in those segments with systolic 
and diltiazem-treated groups during ischemia and reflow. 
thinning during ischemia; thus, segments with the most 
severe ischemic dysfunction benefited most; and 4) there 
were no important differences in regional myocardial blood 
flow during ischemia and reperfusion between saline- and 
diltiazem-treated animals. 
(J Am Co11 Cardioll990;15:737-47) 
fusion is essential for tissue survival (l-5), it provides the 
substrate for a new set of events, which themselves may 
superimpose a significant component of injury (6-9). Thus, 
during coronary artery occlusion, the severity and duration 
of ischemia importantly affect postischemic myocardial 
function (10-13). At reperfusion, factors such as cytosolic 
calcium overload (6,8,14-16), oxygen free radical generation 
(17-21) and leukocyte influx (22-24) may become critical 
determinants of postischemic contractile behavior. Although 
clinical modification of events occurring during the ischemic 
period is not easily feasible, manipulation of reperfusion- 
associated injurious effects may permit significant modula- 
tion of myocardial function after thrombolytic therapy. 
Thus, an understanding of the mechanisms and relative 
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contributions of reperfusion-related factors to postischemic 
myocardial function is important. 
With reperfusion of ischemic myocardium, calcium accu- 
mulates both in the cytosol and in mitochondria of injured 
myocytes (6-9,14-16,25-34). Several mechanisms that con- 
tribute to cellular calcium overload may act singly or in 
concert. These include increased influx through membrane 
calcium channels (31-34) or as a result of membrane defects 
secondary to ischemic membrane injury (35,36). Increased 
intracellular sodium concentrations occurring with ischemia 
may promote increased sodium-calcium exchange and con- 
current calcium accumulation (37-40). Inappropriate intra- 
cellular compartmentalization of Ca2+ (36,41) as a result of 
altered release or uptake of calcium by the sarcoplasmic 
reticulum may also contribute to abnormal calcium homeo- 
stasis. The specific mechanisms involved in a given instance 
may depend on the severity and duration of ischemic cell 
injury. 
Regardless of the mode of accumulation, increased cellu- 
lar calcium adversely affects contractile behavior. In con- 
trast, if calcium accumulation during reperfusion of ischemic 
myocardium is controlled, contractile function is signifi- 
cantly enhanced (27,28,36-38,42). Because of evidence sup- 
porting the deleterious functional consequences of reperfu- 
sion-associated calcium overload, we tested the hypothesis 
that limitation of intracellular calcium by antagonism of 
calcium entry through membrane calcium channels will 
enhance recovery of segmental systolic function after 15 min 
of ischemia and during 24 h of reperfusion in a canine model. 
Furthermore, we examined the relation between gradation of 
ischemic segmental dysfunction and recovery of systolic 
thickening with and without diltiazem treatment. 
Methods 
This study was approved by the Institutional Review 
Board for Animal Experimentation. Care of the animals 
conformed to guidelines defined by the National Institutes of 
Health and the Food and Drug Administration. 
Surgical preparation. Conditioned mongrel dogs of either 
gender weighing 25 to 35 kg were anesthetized with sodium 
pentobarbital (25 mg/kg body weight) and mechanically 
ventilated with room air. After a thoracotomy was made in 
the fifth left intercostal space and the heart suspended in a 
pericardial cradle, a Konigsberg catheter was inserted into 
the left ventricular apex for measurement of left ventricular 
pressure and its first derivative (dP/dt). Intraaortic and left 
atria1 catheters were then placed. A balloon occluder made 
of polyvinyl chloride was secured around the left anterior 
descending coronary artery after the first diagonal branch. A 
10 to 15 s test inflation of this occluder was performed to 
estimate the ischemic area visually. After this, four to five 
pairs of 5 MHz pulse transit piezoelectric crystals were 
distributed in the ischemic and nonischemic regions of the 
Figure 1. Schematic representation of the surgical preparation, 
showing placement of aortic (Ao), left atria1 and micromanometer- 
tipped pressure catheters, left anterior descending (LAD) coronary 
artery occluder and sonomicrometer crystals relative to the region 
of ischemia as indicated by the cyanotic zone. 
left ventricle (Fig. 1). The chest was closed, air evacuated 
and all catheters exteriorized through a stab wound in the 
back of the neck. The dogs were allowed to recover for 
1 week before undergoing the experimental protocol. 
Measurement of segmental systolic wall thickening. The 
methods of Sasayama et al. (43) and Roan et al. (44,45) were 
used to measure segmental systolic wall thickening. Four to 
five pairs of 5 MHz ultrasonic crystals were placed in an 
endocardial to epicardial orientation within the cyanotic 
ischemic zone, the border zone and nonischemic control 
regions. The epicardial crystals were sutured to the surfaces 
of the heart and the endocardial crystal was inserted tangen- 
tially through the myocardium, so that injury to the segment 
to be studied was avoided. Optimal position was determined 
by visual inspection of an oscilloscopic signal. For analysis 
of the signals, the transit time of ultrasound was converted to 
distance, assuming a velocity of sound in myocardium of 1.5 
mm/ps. Data from crystal pairs that showed a suboptimal 
signal were discarded. Systolic wall thickening was mea- 
sured as the difference in millimeters between the end- 
diastolic dimension (the dimension at the point just before 
the onset of the positive dP/dT signal) and that at end-systole 
(maximal systolic excursion occurring between peak posi- 
tive and peak negative dP/dT) (Fig. 2). 
Measurements of wall thickening were expressed as a 
percent of control values. Control values were those taken 
30 min after drug or saline solution infusion, but before 
coronary artery occlusion. Segments were separated into 
functional classes according to the scheme described by 
Roan et al. (44,45). Briefly, segments were classified accord- 
ing to percent of control systolic thickening retained at 15 
min after occlusion. Class 1 segments were those retaining 
>67% of control thickening; class 2 segments were those 
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Figure 2. Sample record obtained at control 
study and during coronary artery occlusion. ECG 
= continuously recorded lead II electrocardio- 
gram; dP/dT = first derivative of left ventricular 
pressure; LV = left ventricle. 
retaining between 0% and 67% of control thickening and 
class 3 segments were those retaining ~0% thickening (that 
is, segments with systolic wall thinning). Net systolic thick- 
ening in this scheme is defined as the extent of systolic wall 
thickening minus the amount of any systolic thinning lasting 
for longer than half of systole (45,46). 
Measurement of regional myocardial blood flow and deter- 
mination of tissue necrosis. Regional myocardial blood flow 
was measured with radiolabeled 15 pm diameter carbonized 
microspheres (44,45). Microspheres were suspended in a 
solution containing 10% dextran and 0.01% Tween 80, 
mechanically agitated and then injected into the left atrium. 
A simultaneous reference central arterial blood sample was 
withdrawn at a constant rate by pump from the aortic 
catheter. 
At the conclusion of the experimental protocol, the dogs 
were heparinized with 10,000 U of heparin intravenously and 
deeply anesthetized with sodium pentobarbital(25 mglkg). A 
second large dose of sodium pentobarbital (75 mg/kg) was 
given to cause cessation of cardiac contraction. The heart 
was excised, washed and placed in buffered formalin. After 
fixation, the heart was sliced into seven to eight equal 
thickness slices parallel to the atrioventricular groove. 
Transmural tissue samples between crystal pairs and from a 
remote control region in the circumflex coronary artery 
distribution were divided into endocardial, midmyocardial 
and epicardial segments, weighed and placed formalin and 
then into a scintillation counter for determination of regional 
myocardial blood flow. Regional myocardial blood flow was 
calculated by a computer-assisted program (44,45) in which 
flow is determined by the general formula: Qrn = Qr x 
Cm/G, where Qm = myocardial flow (mumin), Qr = refer- 
ence blood flow (ml/min), Cm = counts/min in myocardium 
and Cr = counts/min in the reference blood sample. The 
tissue samples were then reassembled, embedded in paraffin, 
sectioned and stained with hemotoxylin-eosin. After this, 
sections were carefully examined to confirm the absence of 
recent necrosis. Dogs with evidence of recent myocardial 
necrosis were excluded from further analysis. 
Experimental protocol. When the dogs had recovered 
from surgery for r7 days, they were taken to the laboratory 
and placed in a standing sling in the awake unsedated state. 
Care was taken to ensure that the dogs were comfortable and 
unstressed. 
Protocol 1. Eighteen dogs were entered into this proto- 
col. and 13 dogs survived two coronary artery occlusions of 
15 min each, followed by 24 h of reperfusion. Only dogs 
surviving both occlusions were included in the data analysis. 
The occlusions were separated by at least 3 days. One 
occlusion was performed during infusion of diltiazem (Mar- 
ion Laboratories) dissolved in normal saline solution at the 
dose of 15 kg/kg per min; the other occlusion was performed 
during infusion of an equal volume of saline solution, Infu- 
sions were begun 30 min before occlusion and continued 
over 3 h of reperfusion. The order of the infusion was 
alternated to obviate an effect of sequential occlusions. 
Before each occlusion, dogs were pretreated with lidocaine 
in the following dosage schedule: 1.5, 1 .O, 0.8 and 0.8 mglkg 
as intravenous bolus injections at 10 min intervals, followed 
by intravenous infusions at rates of 2 mglmin. 
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Protocol 2. Because diltiazem infusion was associated 
with mild decreases in mean arterial pressures, an additional 
group of 10 dogs underwent a single 15 min coronary artery 
occlusion during infusion of sodium nitroprusside at doses 
titrated to achieve a reduction in mean arterial blood pres- 
sure similar to that seen during diltiazem infusion. 
Measurements. During the experimental period, the fol- 
lowing hemodynamic measurements were recorded on a 
Hewlett-Packard four channel recorder: heart rate, left ven- 
tricular pressure, the first derivative of left ventricular pres- 
sure (dP/dt), aortic pressure and phasic and mean left atria1 
pressures. A lead II electrocardiogram, left ventricular pres- 
sure, dP/dt and regional wall thickening from the four to five 
pairs of ultrasonic crystals were recorded on a Hewlett- 
Packard eight channel recorder. Records for analysis of 
hemodynamic variables were obtained at a paper speed of 25 
mm/s and for analysis of regional wall thickening at a speed 
of 50 mm/s. Recordings of hemodynamic variables and 
regional wall thickening were made in the control period 
(before coronary artery occlusion but after administration of 
diltiazem, saline solution or nitroprusside), immediately 
after occlusion and 15 min after occlusion, at reflow and at 
10, 15, 30, 60, 120 and 180 min and 24 h of reflow. 
Statistical analyses. A repeated measures analysis of vari- 
ance was performed to assess whether or not effects of time 
and individual variability among dogs were responsible for 
the changes in function during the experiment. For this 
analysis, we stratified our sample by treatment and level of 
function and looked at the effects of time and variation on 
regional cardiac function among individual dogs. Similarly, 
to assess the effect of treatment and variation on regional 
cardiac function among individual dogs, we stratified by time 
and functional level and performed a one way analysis of 
variance. Variation among individual dogs was not suffi- 
ciently significant to explain differences between treatment 
groups; however, time and treatment did exert significant 
effects. 
Segmental function, hemodynamic variables and regional 
myocardial blood flow over time for each treatment group 
were analyzed by using multiple Student’s t tests, with a 
Bonferroni adjustment of the p value based on the number of 
comparisons. Segmental function and regional myocardial 
blood flow at given time points among treatment groups were 
compared by unpaired t tests, with a Bonferroni correction 
when more than a single comparison was made. Hemody- 
namic variables at given time points were compared among 
saline solution-, diltiazem- and nitroprusside-treated occlu- 
sions by t tests, with corrections of the p values based on 
three comparisons. 
Results 
Data from individual dogs were included in the final 
analysis if two criteria could be met: 1) the dog survived both 
Table 1. Paired Comparison of Segmental Systolic Thickening 
Before and After Drug Infusion 
Mean 
Treatment Difference 
Class Group k SEM p Value 
1 S 3.0 + 6.1 0.67 
D 0.4 * 9.5 0.96 
N -6.7 + 3.8 0.11 
2 s -6.2 f 5.3 0.2 
D 14.5 ? 7.4 0.07 
N 0.9 2 5.4 0.86 
3 s -0.5 + 13.7 0.9 
D -1.2 + 9.4 0.9 
N 3.6 + 4.2 0.43 
Treatment groups are indicated as follows: D = diltiazem; N = nitroprus- 
side; S = saline solution; SEM = standard error of the mean. 
coronary artery occlusions of Protocol 1 or the single occlu- 
sion of Protocol 2. Thus, four dogs that died from ventricular 
fibrillation during occlusion or at reflow were excluded. 
Another dog that died during reflow from hemorrhage 
around the site of the Konigsberg catheter was also ex- 
cluded. 2) Regional blood flow and function analyses con- 
firmed that effective occlusions and reperfusion occurred. 
Three occlusions were excluded from analysis because of 
evidence of malfunction of the externalized occluder. There 
was acute necrosis histologically after one of the three 
occlusions, further substantiating the ineffective reperfu- 
sion. The total number of animals and occlusions in each 
protocol were as follows: Protocol 1 (alternate infusion of 
diltiazem or saline solution), 13 dogs: 13 diltiazem-treated 
occlusions, 12 saline solution-treated occlusions. Protocol 2 
(nitroprusside infusion), 10 dogs: 10 nitroprusside-treated 
occlusions. 
The number of left ventricular segments in each class and 
treatment group were asfollows: class 1: saline solution, 12 
segments; diltiazem, I5 segments; nitroprusside, 12 seg- 
ments. Class 2: saline solution, 20 segments; diltiazem, 20 
segments; nitroprusside, 17 segments. Class 3: saline solu- 
tion, 15 segments; diltiazem, 15 segments; nitroprusside, 6 
segments. 
Segmental systolic thickening. Control segmental wall 
thickening was measured at 30 min of drug or saline solution 
infusion, but immediately before coronary artery occlusions. 
Because of the concern that diltiazem or nitroprusside 
infusion may have significantly altered function before oc- 
clusion, thereby resulting in different absolute levels of 
control function in the two groups, we compared segmental 
systolic thickening before infusion with that at 30 min of 
infusion by paired t tests (Table 1). Segmental systolic 
function was not significantly different at these two time 
points groups treated with saline solution, diltiazem or 
nitroprusside. 
JACC Vol. 15, No. 3 
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The evolution of systolic segmental myocardial thicken- 
ing (expressed as a percent of control values) for each class 
of crystal and each treatment group is summarized in Figure 
3. There were no significant differences in function at any 
time point among saline solution-, diltiazem- and nitroprus- 
side-treated class 1 (Fig. 3A) or class 2 (Fig. 3B) segments. 
In contrast. significant functional differences evolved in 
class 3 segments (Fig. 3C), that is, those segments with CO% 
of control thickening (systolic wall thinning) at 15 min of 
coronary artery occlusion. At 15 min of occlusion, the 
degree of ischemic dyskinesia was identical in the three 
treatment groups. On reperfusion, however, important func- 
tional divergences were observed. At all time points during 
reperfusion, segmental systolic thickening was better pre- 
served in the diltiazem-treated segments than in saline 
solution-treated segments, with the differences achieving 
statistical significance compared with saline solution at im- 
mediate reflow and at 10, 30 and 120 min of reflow. In the 
nitroprusside-treated segments, function was not signifi- 
cantly better than that in segments treated with saline 
solution until 120 min of reflow, although there was a trend 
toward enhanced function at earlier time points. When 
diltiazem-treated segments were compared with nitroprus- 
side-treated segments, the differences in segmental thicken- 
ing were not significantly different at any time point. Thus, 
reduction in arterial pressure had an effect intermediate 
between that from treatment with saline solution or diltiazem 
(Fig. 3D). This finding contrasts with the findings in class 1 
and class 2 segments, where there were no significant 
differences in segmental systolic function among the three 
treatment groups at any time point. 
When the time at which sustained return to control 
thickening was considered, class 3 segments in the diltiazem- 
treated group again fared better. Diltiazem-treated segments 
had sustained return to control thickening at immediate 
reperfusion compared with 120 min for nitroprusside-treated 
segments and 180 min for saline solution-treated segments. 
Class 1 segments in saline solution-, diltiazem- and nitro- 
prusside-treated coronary artery occlusions had very little 
deviation from control function. Class 2 segments exhibited 
very little difference in recovery of function among the three 
treatment groups. 
Hemodynamics. When hemodynamic variables in the 
three treatment groups were compared (Fig. 4), significant 
differences were found only with respect to arterial pressure 
and left atria1 mean pressure. Systolic, diastolic and mean 
arterial pressures were slightly but significantly reduced 
during both diltiazem and nitroprusside infusion. Despite an 
identical reduction in mean arterial pressure, only the dil- 
tiazem-treated class 3 segments showed significantly en- 
hanced early recovery of segmental thickening compared 
with that in segments treated with saline solution. Heart rate 
(Fig. 4, bottom panel) tended to be somewhat higher during 
diltiazem and nitroprusside infusion than during saline solu- 
tion infusion. but the differences were not statistically sig- 
nificant. Thus, the double product (heart rate time systolic 
blood pressure) was not different at any time among groups. 
Regional myocardial blood flow (Table 2). In class i 
segments, blood flow during coronary artery occlusion and 
reperfusion was not different from control values in either 
the diltiazem- or saline solution-treated occlusions. In class 
2 and class 3 segments, regional myocardial blood flow wac 
significantly reduced during coronary artery occlusion com- 
pared with control. Importantly, when blood flow at each 
time point was compared, there were no differences in blood 
flow between saline solution- and diltiazem-treated groups 
during coronary occlusion and at reflow except in the 
epicardial portions of class 3 segments. The difference waq 
small (0.3 ml/g tissue per min); however, statistical signifi- 
cance was achieved. Importantly, blood flow was not statis- 
tically different in this class of segments in the endocardial 01’ 
midmyocardial portions. Thus, diltiazem neither alleviated 
the severity of ischemia nor improved blood flow at 30 min of 
reperfusion in class 2 or class 3 segments. 
Histology. When histologic sections of myocardium be- 
tween sonomicrometer crystal pairs were examined, some 
sections showed foci of fibrosis and inflammation routinely 
found in association with long-term sonomicrometer implan- 
tation (44,45). One of the 13 hearts had evidence of recent 
myocardial necrosis occurring after a second occlusion that 
had been treated with saline solution infusion. Flow as well 
as functional data pointed to failure of reperfusion; thus, 
functional data from this occlusion were excluded from 
analysis. 
Discussion 
Effect of diltiazem on segmental systolic thickening during 
reperfusion. Because the threshold for irreversible myocar- 
dial injury is reached at approximately 20 min of ischemia 
(1,2), a coronary occlusion period of 15 min duration results 
in structural and functional alterations that are ultimately 
fully reversible (1,2,46,47). Thus, the effect of calcium 
channel blockade on postischemic systolic function could be 
evaluated in this experiment without differences in the 
amount of tissue necrosis as a factor in functional recovery. 
The principal finding of this study using a model of brief 
coronary occlusion was that diltiazem infusion (15 pg/kg per 
min) significantly enhanced recovery of segmental systolic 
thickening during reperfusion after 15 min of ischemia in the 
absence of improved function during ischemia. Improve- 
ment in contractile function was seen only in those segments 
with systolic thinning during ischemia; thus, segments with 
the most severe ischemic dysfunction benefited most. Al- 
though regional myocardial blood flow was enhanced before 
coronary occlusion, there were no important differences in 
regional myocardial blood flow between diltiazem- and sa- 
line solution-treated occlusions during ischemia and at 30 
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min of reperfusion. Diltiazem, therefore, did not exert a 
beneficial effect by allediating the intensity of ischemia nor 
by augmentating blood flow during reperfusion. Arterial 
pressures were slightly but significantly reduced by dilti- 
azem; an identical reduction in mean arterial pressure by 
nitroprusside infusion resulted in functional recovery inter- 
mediate between that occurring with infusion of saline 
solution and diltiazem, suggesting that afterload reduction 
by diltiazem only partially accounted for the early enhance- 
ment in functional recovery seen in this treatment group. 
Table 2. Regional Myocardial Blood Flow by Class of Ischemic Segment 
Treatment 
Class Levei No. Group Control Occlusion Reflow 
I Epi 
Mid 
Endo 
2 Epi 
Mid 
Endo 
3 Epi 
Mid 
Endo 
8 S 
11 D 
8 S 
11 D 
8 S 
11 D 
15 s 
15 D 
15 S 
15 D 
15 S 
15 D 
11 S 
7 D 
11 S 
I D 
11 S 
7 D 
0.91 f 0.28 1.04 * 0.33 
1.49 2 0.75* 1.47 ? 0.44* 
1.20 + 0.28 1.36 + 0.32 
1.68 ? 0.95 1.72 + 0.67 
1.11 ? 0.26 1.25 t 0.25 
1.58 k 0.82 1.61 + 0.61 
1.04 f 0.43 0.85 + 0.49 
1.86 ? 0.85 0.95 t 0.W 
1.33 2 0.56 0.88 r 0.73 
2.27 ? 1.21* 0.88 + 0.57’F 
1.40 + 0.60 0.90 r 0.80f 
2.47 ? 1.43* 0.97 + 0.72t 
0.95 + 0.30 0.51 t 0.34t 
1.37 2 0.47 0.54 2 0.41t 
1.31 k 0.45 0.56 + 0.49t 
1.73 + 1.06 0.58 t 0.69t 
1.30 + 0.41 0.63 + 0.6Ot 
2.00 r 2.00 0.68 ?r 0.72 
1.08 + 0.18 
1.20 + 0.19 
1.47 t 0.24t 
1.34 + 0.28 
1.35 t 0.24 
1.24 + 0.32 
1.10 + 0.39 
1.17 + 0.26t 
1.34 + 0.50 
1.25 + 0.34t 
1.30 + 0.50 
1.34 + 0.30t 
0.86 ? 0.23 
1.11 ? 0.22’ 
1.10 + 0.26 
1.21 + 0.32 
1.07 ? 0.31t 
1.19 2 0.31 
*p 5 0.05 saline solution (S) versus diltiazem (D); tp 5 0.05 versus control within any treatment group. Regional 
myocardial blood flow is expressed in ml/g myocardium per min; values shown are mean value 2 SD. Endo = 
endocardium; Epi = epicardial; Mid = mid wall; other abbreviations as in Table 1. 
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Myocardial consequences of reperfusion. Myocardium 
that has undergone ischemia followed by reperfusion differs 
from permanently ischemic myocardium biochemically, ul- 
trastructurally and functionally (48). Prominent biochemical 
features of reperfused myocardium include increases in cell 
water, sodium and chloride (14,49,50), as well as prolonged 
but reversible depression in high energy phosphate concen- 
tration (4). Severely injured myocytes also show evidence of 
contraction bands and prominent electron-dense mitochon- 
drial granules consisting of calcium phosphate precipitates 
(1,4,5). Functionally, systolic thickening recovers slowly 
over a period of time usually substantially longer than the 
ischemic interval (12,13,46,47,51). Thus, both the severity of 
biochemical, ultrastructural and functional impairment and 
the time course of recovery are linearly related to the 
intensity and duration of ischemia. The final extent of 
segmental functional recovery is inversely related to these 
factors. Although many factors undoubtedly influence re- 
covery of segmental function after transient ischemia, main- 
tenance of calcium homeostasis may be particularly impor- 
tant. 
In reperfused myocardium, calcium overload is promi- 
nent ultrastructurally (1,6,14,15,34,49) and has adverse con- 
sequences functionally (27,28,30,31). The most extensive 
calcium accumulation, which has been found in irreversibly 
injured cells, is thought to occur as a consequence of loss of 
membrane integrity, with diffusion of calcium down an 
electrochemical gradient (14,29) or as the result of an inabil- 
ity of intracellular calcium storage sites to sequester calcium 
normally, or both. In reversibly injured cells, however, 
lesser amounts of calcium accumulate with ischemia and 
reperfusion; importantly, calcium may accumulate in the 
absence of morphologic alteration in membrane integrity 
(31,32,34,39,52) and, thus, may enter by physiologic path- 
ways that may have been altered by ischemia. The mecha- 
nism or mechanisms that might singly, simultaneously or 
sequentially facilitate entry or accumulation, or both, of 
excessive amounts of calcium in reversibly injured cells 
include the membrane slow inward calcium current, the 
sodium-calcium exchanger or the altered release or uptake of 
intracellular calcium stores by the sarcoplasmic reticulum. 
Calcium channel blockade during ischemia and reflow. 
One potential physiologic route of calcium entry during 
ischemia as well as at reperfusion may be through membrane 
calcium channels (53). Diltiazem is a calcium channel antag- 
onist that inhibits myocardial calcium entry by blockade of 
voltage-dependent membrane calcium channels (54,55). Al- 
though calcium channel antagonists all inhibit calcium chan- 
nel conductance, they exhibit considerable selectivity of 
action (54,55); thus, vasodilation, negative inotropy and 
chronotropic effects vary among the agents. It is conceivable 
that protection of the myocardium during ischemia and 
reperfusion may also vary among calcium antagonists. 
Diltiazem treatment of the isolated myocyte or cardiac 
muscle strip results in dose-dependent negative inotropy and 
chronotropy, as well as relaxation of vascular smooth mus- 
cle (56). These effects of diltiazem noted in the isolated cell 
or organ system, however, are modulated in the intact 
unsedated animal. Thus, Millard et al. (56) found that 30 
E.Lg/kg of diltiazem administered intravenously in conscious 
dogs resulted in a mild diminution of blood pressure reflec- 
tive of peripheral vasodilation, but in increases in heart rate 
mediated by reflex sympathetic responses. The hemody- 
namic results of our study confirm these findings. Although 
blood pressure was slightly decreased by diltiazem, heart 
rate was slightly increased (Fig. 4). The heart rate-blood 
pressure product and contractility, expressed by the rate of 
left ventricular pressure development were, therefore, not 
different during diltiazem or saline solution treatment. 
Coronary vasodilation by diltiazem results in augmenta- 
tion of coronary bloodjlow (56-58); however, enhanced how 
in nonischemic tissue has not been shown to result in 
increased systolic segmental function (59). In this study, we 
found a trend toward increased regional myocardial blood 
flow at control measurements in the diltiazem-treated seg- 
ments, but found no difference between control preocclusion 
systolic thickening in saline solution- and diltiazem-treated 
groups (Table 1). Although regional myocardial blood flow 
tended to be somewhat enhanced before coronary artery 
occlusion during diltiazem infusion, flow during ischemia 
and at 30 min of reperfusion was not significantly different in 
the saline solution- and diltiazem-treated groups. The only 
exception was a small increase in blood flow to the epicardial 
third of the class 3 segments. Although this difference was 
significant, it was small (0.3 ml/g tissue per min) and of 
questionable physiologic importance because segmental 
function is far more sensitive to changes in endocardial 
blood flow (44). We, therefore, could not conclude that‘the 
beneficial effect of diltiazem was based on alleviation of 
ischemia or enhanced regional blood flow during the reper- 
fusion period. Despite equal reductions in blood flow and 
function during ischemia in diltiazem- and saline solution- 
treated groups, we cannot, however, exclude the possibility 
that diltiazem’s beneficial effect did not result from protec- 
tion from the effects of ischemia. 
Mechanisms of protective effect of calcium channel block- 
ers on ischemic myocardium. Treatment of ischemic myo- 
cardium with calcium channel blockers before coronary 
artery occlusion has been found to decrease ultrastructural 
evidence of injury (34,60,61), decrease calcium influx 
(34,61,62) and improve postischemic left ventricular segmen- 
tal function (57,58,62-65). When given after occlusion but 
before reperfusion, calcium channel blockers may still be 
protective (63,64,66). Bush et al. (64) found that diltiazem 
begun 30 min after occlusion but before reperfusion pre- 
vented worsening of segmental systolic function associated 
with reperfusion after 2 or 4 h of coronary artery occlusion. 
This observation strongly suggests that diltiazem provided 
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protection from further injury associated with reperfusion. 
Przyklenk and Kloner (63) also found that treatment with 
verapamil before ischemia, at reperfusion and after reperfu- 
sion resulted in improved segmental shortening after 15 min 
of ischemia and 3 h of reperfusion in an anesthetized open 
chest canine preparation. Because most studies have shown 
that calcium channel blockers provide benefit when given 
before ischemia or before but not at reperfusion, it has been 
postulated that benefit is due to protection from the effects of 
ischemia rather than from decreases in reperfusion-related 
calcium influx. An alternative hypothesis to explain why 
calcium channel blockers provide benefit when given before 
reperfusion may be that the time required for drug binding 
and action may be longer than the time required for calcium 
influx at reperfusion. 
Diminution of ischemic adenosine triphosphate (ATP) 
catabolism has been suggested (58,60,61) to be a mechanism 
by which calcium channel blockers may protect ischemic 
myocardium independent of their effects on calcium entry. 
Several authors (60-62,67) have shown preserved levels of 
ATP associated with pretreatment with verapamil (60- 
62,67) and diltiazem (58,60). Watts et al. (67) and Przyklenk 
and Kloner (63) showed that pretreatment with verapamil 
resulted in both enhanced functional recovery and preserva- 
tion of ATP. However, functional recovery was not well 
correlated with the degree of ATP preservation. Kusuoka et 
al. (42) have shown that myocardial ATP after ischemia. 
measured by phosphorus nuclear magnetic resonance, did 
not correlate with functional recovery. Thus, even though 
preservation of ATP may be an important contributor to 
ultimate cell survival, it may not be the principal determinant 
of functional recovery after brief coronary artery occlusion. 
A third mechanism by which calcium channel blockers 
have been postulated to enhance the function of ischemic 
myocardium is by exerting a negative inotropic effect, re- 
sulting in diminution of energy utilization rather than any 
change in catabolism (62,67). However, a protective effect of 
calcium channel blockers has been noted in the absence of 
decreases in heart work (60) or negative inotropy. 
Role of afterload reduction. We considered that the mild 
decrease in blood pressure afforded by diltiazem in our study 
may have been the important determinant of enhanced 
recovery of segmental thickening by diltiazem; however, 
identical reductions in mean arterial pressure in the nitro- 
prusside-treated group did not result in equivalent improve- 
ments in function (Fig. 3C and D). The fact that the nitro- 
prusside-treated class 3 segments had functional recovery 
intermediate between that of saline solution- and diltiazem- 
treated segments can best be interpreted as showing that 
afterload reduction may be responsible for part but not all of 
the beneficial effect of diltiazem in reperfused myocardium. 
Other studies (59) also suggest that the reduction in afterload 
is not the sole determinant of postischemic function. Thus, 
we conclude that afterload reduction within the range of our 
experiment does not fully explain the beneficial effect of 
diltiazem. 
Role of decreased calcium accumulation at reperfusion. 
Finally, diltiazem has been found to decrease intracellular 
calcium accumulation at reperfusion (34,61,65). Decreases in 
calcium accumulation have been reported to correlate with 
decreased histologic injury (34) and improved function (65). 
A role for calcium channels in reperfusion-associated cal- 
cium gain has also been suggested by studies of adrenergic 
blockade. Sharma et al. (32) found that reperfusion- 
associated calcium accumulation could be prevented or 
attenuated by adrenergic blockers administered before 
ischemia. They postulated an increase in alpha-adrenergic 
receptor density during ischemia, resulting in enhanced 
alpha-agonist augmentation of calcium-dependent inward 
currents and, thus, facilitation of calcium accumulation 
through calcium channels during ischemia. In support of an 
interaction between adrenergic factors and calcium channel 
conductance are studies (56) showing that some calcium 
antagonists inhibit calcium uptake induced by isoproterenol. 
The quantity of calcium accumulation led these investigators 
and others to conclude that alpha-adrenergic blockers influ- 
enced sites other than membrane calcium channels. How- 
ever, Green et al. (68) observed that in isolated myocytes, 
binding sites of nitrendipine, a dihydropyridine calcium 
antagonist, reversibly increased by 115% as a function of 
increasing membrane depolarization. Thus, ischemia may 
modify calcium channel conductance, such that entry of 
calcium may be facilitated. 
Calcium and reperfusion injury. Irrespective of the 
modes of calcium entry, limitation of calcium entry during 
reperfusion has been shown to be functionally and ultra- 
structurally beneficial. Shine and Douglas (27) demonstrated 
significantly greater recovery of ATP and mechanical func- 
tion when the isolated rabbit interventricular septum was 
reperfused with low calcium solution during the first 5 min of 
reperfusion after 45 min of ischemia. Low calcium reperfu- 
sion has been shown to result in preservation of developed 
pressure in isolated ferret hearts (42) and decreased ultra- 
structural injury in canine models (69). 
Conversely. Kitakaze et al. (70) reported that both con- 
tractile function and ATP were transiently depressed in 
isolated hearts by exposure to 10 m&I calcium solution in the 
absence of ischemia. Histologically, these myocytes ap- 
peared to have ultrastructural changes consistent with mild 
reversible injury. These investigators concluded that tran- 
sient calcium overload resulted in all the features of 
“stunned myocardium.” 
Conclusion. Using an awake, unsedated, chronically in- 
strumented canine model undergoing brief coronary artery 
occlusion, we found that treatment with diltiazem resulted in 
significantly improved recovery of regional systolic thicken- 
ing in segments with the most severe ischemic dysfunction. 
Improvement occurred independently of the reduction in 
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mean arterial pressure by diltiazem and in the absence of 
alteration in heart rate-blood pressure product or left ven- 
tricular dP/dt. Benefit also occurred in the absence of 
enhanced regional myocardial blood flow during ischemia 
and reperfusion. Although the severity and duration of 
ischemia will obviously influence the extent of myocardial 
recovery by determining the amount of irreversibly injured 
tissue, it is thought-provoking to speculate that the pro- 
longed time course of recovery of reversibly injured tissue 
(that is, myocardial stunning) may be more critically influ- 
enced by the events at reperfusion. If this were so, it is 
possible that mechanically directed modification of reperfu- 
sion might permit more complete early salvage of reversibly 
injured myocardium after thrombolysis. 
We are most appreciative of the expert secretarial assistance of Carolyn 
Donahue, the superb surgical support of Judy Ober and the statistical advice 
of Walter Johnston, PhD and Joan Reisch, PhD. 
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